Danaher Corp. has announced that it has entered into a definitive agreement to acquire PaloDEx Holding Oy (“PaloDEx”), a leading manufacturer of dental imaging products with revenues of more than $100M that goes to market under the Instrumentarium Dental and SOREDEX brands. The transaction is subject to regulatory approval and customary closing conditions. Instrumentarium Dental and SOREDEX will join Gendex, DEXIS, ISI, KaVo and Pelton & Crane as part of Danaher’s group of dental equipment companies.

PaloDEx’s product range includes 3D CBCT, Panoramic x-ray (including the OP200), PSP (including the Optime IO PSP) and other intra-oral and extra-oral xray imaging systems.

“We believe this acquisition will be a game-changer for both of our companies and we are excited about the opportunity to acquire two of the leading imaging brands. Instrumentarium Dental and Soredex’s excellent digital imaging products and technology will be a great fit with our existing Gendex, DEXIS and i-CAT business. PaloDEx has a very experienced team and we look forward to working with Henrik Roos, President of PaloDEx, and his team as we continue to build the business,” said Henk van Duijnhoven, Group Executive of Danaher’s KaVo Group.

Henrik Roos will remain in his position and added: “I am thrilled to join Danaher’s dental business. The combined business will create a unique opportunity to provide new and innovative technologies in digital dentistry with focus on diagnostics and treatment planning for general practitioners and specialists.”